Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|November 16, 2012
Response assessment in Waldenström macroglobulinaemia: update from the VIth International WorkshopRoger G Owen, Robert A Kyle, Marvin J Stone, et al.
Advances in Therapy|February 24, 2024
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple MyelomaHermann Einsele, Philippe Moreau, Nizar Bahlis, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 30, 2021
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter AnalysisArtur Jurczyszyn, Jorge J Castillo, Magdalena Olszewska-Szopa, et al.
Annals of Hematology|June 24, 2025
Prognostic factors of survival in second allogeneic hematopoietic transplantationRodrigo Cantera Estefanía, Raquel García Ruiz, Sara Fernández-Luis, et al.
Blood|January 13, 2016
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistanceBruno Paiva, Luis A Corchete, Maria-Belen Vidriales, et al.
Haematologica|July 10, 2012
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometryRoberto J Pessoa de Magalhães, María-Belén Vidriales, Bruno Paiva, et al.
Blood|May 27, 2016
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myelomaMeletios A Dimopoulos, Antonio Palumbo, Paolo Corradini, et al.
Blood Cancer Journal|March 20, 2019
Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signaturePaula Rodríguez-Otero, María Victoria Mateos, Joaquín Martínez-López, et al.
Leukemia|March 9, 2019
Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability rolePaula Rodríguez-Otero, María Victoria Mateos, Joaquín Martínez-López, et al.
Haematologica|April 27, 2023
Randomized phase II study of weekly carfilzomib 70 mg/m<sup>2</sup> and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patientsBorja Puertas, Verónica González-Calle, Anna Sureda, et al.
Pageof 13